EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Differences in treatment of stage I colorectal cancers: a population-based study of colorectal cancers detected within and outside of a screening program

Esther Toes-Zoutendijk iD, Emilie C H Breekveldt, Lisa van der Schee, Iris D Nagtegaal, Marloes A G Elferink, Iris Lansdorp-Vogelaar, Leon M G Moons, Monique E van Leerdam

Endoscopy · 01.01.2024 · 56 (01) · 5-13

DOI: 10.1055/a-2173-5989 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.01.2024. Verfasst von Esther Toes-Zoutendijk und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Rectal Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Screen-detected colorectal cancers (CRCs) are often treated less invasively than stage-matched non-screen-detected CRCs, but the reasons for this are not fully understood. This study evaluated the treatment of stage I CRCs detected within and outside of the screening program in the Netherlands.

Methods

Data from the Netherlands Cancer Registry for all stage I CRCs diagnosed between January 1, 2008 and December 31, 2020 were analyzed, comparing patient, tumor, and treatment characteristics of screen-detected and non-screen-detected stage I CRCs. Multivariable logistic regression was used to assess the association between treatment (local excision only vs. surgical oncologic resection) and patient and tumor characteristics, stratified for T stage and tumor location.

Results

Screen-detected stage I CRCs were relatively more often T1 than T2 compared with non-screen-detected stage I CRCs (66.9 % vs. 53.3 %; P < 0.001). When only T1 tumors were considered, both screen-detected colon and rectal cancers were more often treated with local excision only than non-screen-detected T1 cancers (odds ratio [OR] 2.19, 95 %CI 1.93–2.49; and OR 1.29, 95 %CI 1.05–1.59, respectively), adjusted for sex, tumor location, lymphovascular invasion (LVI) status, and tumor differentiation.

Conclusions

Less invasive treatment of screen-detected stage I CRC is partly explained by the higher rate of T1 cancers compared with non-screen-detected stage I CRCs. T1 stage I screen-detected CRCs were also more likely to undergo less invasive treatment than non-screen-detected CRCs, adjusted for risk factors such as LVI and tumor differentiation. Future research should investigate whether the choice of local excision was related to unidentified cancer-related factors or the expertise of the endoscopists.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsRectal NeoplasmsHumansEarly Detection of CancerRisk FactorsColonoscopy

Autor:innen und Institutionen

  • Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Department of Gastrointestinal Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands.
  • Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.

ORCID-Profile: Esther Toes-Zoutendijk

Zitieren

APA

Toes-Zoutendijk, E., Breekveldt, E. C. H., van der Schee, L., Nagtegaal, I. D., Elferink, M. A. G., Lansdorp-Vogelaar, I., Moons, L. M. G., & van Leerdam, M. E. (2024). Differences in treatment of stage I colorectal cancers: a population-based study of colorectal cancers detected within and outside of a screening program. Endoscopy, 56(01), 5-13. https://doi.org/10.1055/a-2173-5989

Vancouver

Toes-Zoutendijk E, Breekveldt ECH, van der Schee L, Nagtegaal ID, Elferink MAG, Lansdorp-Vogelaar I, et al. Differences in treatment of stage I colorectal cancers: a population-based study of colorectal cancers detected within and outside of a screening program. Endoscopy. 2024;56(01):5-13. doi:10.1055/a-2173-5989

BibTeX
@article{ToesZoutendijk2024,
  author = {Toes-Zoutendijk, Esther and Breekveldt, Emilie C H and van der Schee, Lisa and Nagtegaal, Iris D and Elferink, Marloes A G and Lansdorp-Vogelaar, Iris and Moons, Leon M G and van Leerdam, Monique E},
  title = {Differences in treatment of stage I colorectal cancers: a population-based study of colorectal cancers detected within and outside of a screening program},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {01},
  pages = {5--13},
  doi = {10.1055/a-2173-5989}
}
Kostenlos starten →